WALTERS GROUP - 10%+ Owner at Zentalis Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
10%+ Owner
Issuer Symbol
ZNTL on Nasdaq
All Insider Reports
All Insider Reports

WALTERS GROUP - trading volume in the past year for Zentalis Pharmaceuticals, Inc.

Holdings reported by WALTERS GROUP for Zentalis Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 13,509,973 $16,211,967 $1.20 31 Dec 2025 Direct

Transactions reported by WALTERS GROUP for Zentalis Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.